86 related articles for article (PubMed ID: 15376374)
1. [Current status and strategy of research on epitope-based vaccine].
Chen Y; Dai C
Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Sep; 33(5):315-6. PubMed ID: 15376374
[No Abstract] [Full Text] [Related]
2. New tools, new approaches and new ideas for vaccine development.
De Groot AS; Moise L
Expert Rev Vaccines; 2007 Apr; 6(2):125-7. PubMed ID: 17408360
[No Abstract] [Full Text] [Related]
3. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
[TBL] [Abstract][Full Text] [Related]
4. Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine.
Gruener NH; Gerlach TJ; Ulsenheimer A; Diepolder HM; Wierenga E; Zachoval R; Heeg M; Pape GR; Jung MC
Vaccine; 2007 Jun; 25(26):4960-6. PubMed ID: 17466417
[TBL] [Abstract][Full Text] [Related]
5. A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice.
Li X; Yang X; Jiang Y; Liu J
Int Immunol; 2005 Oct; 17(10):1293-302. PubMed ID: 16113237
[TBL] [Abstract][Full Text] [Related]
6. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
Riedl P; Wieland A; Lamberth K; Buus S; Lemonnier F; Reifenberg K; Reimann J; Schirmbeck R
J Immunol; 2009 Jul; 183(1):370-80. PubMed ID: 19542448
[TBL] [Abstract][Full Text] [Related]
7. Enhanced multiepitope-based vaccines elicit CD8+ cytotoxic T cells against both immunodominant and cryptic epitopes.
Tine JA; Firat H; Payne A; Russo G; Davis SW; Tartaglia J; Lemonnier FA; Demoyen PL; Moingeon P
Vaccine; 2005 Jan; 23(8):1085-91. PubMed ID: 15620483
[TBL] [Abstract][Full Text] [Related]
8. Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine.
Xu W; Chu Y; Zhang R; Xu H; Wang Y; Xiong S
Virology; 2005 Apr; 334(2):255-63. PubMed ID: 15780875
[TBL] [Abstract][Full Text] [Related]
9. Epitope-based vaccines: an update on epitope identification, vaccine design and delivery.
Sette A; Fikes J
Curr Opin Immunol; 2003 Aug; 15(4):461-70. PubMed ID: 12900280
[TBL] [Abstract][Full Text] [Related]
10. DNA immunization with 2C FMDV non-structural protein reveals the presence of an immunodominant CD8+, CTL epitope for Balb/c mice.
Barfoed AM; Rodriguez F; Therrien D; Borrego B; Sobrino F; Kamstrup S
Antiviral Res; 2006 Dec; 72(3):178-89. PubMed ID: 16890298
[TBL] [Abstract][Full Text] [Related]
11. Optimisation of secretion of recombinant HBsAg virus-like particles: Impact on the development of HIV-1/HBV bivalent vaccines.
Michel M; Lone YC; Centlivre M; Roux P; Wain-Hobson S; Sala M
Vaccine; 2007 Feb; 25(10):1901-11. PubMed ID: 17005303
[TBL] [Abstract][Full Text] [Related]
12. Major contribution of codominant CD8 and CD4 T cell epitopes to the human cytomegalovirus-specific T cell repertoire.
Nastke MD; Herrgen L; Walter S; Wernet D; Rammensee HG; Stevanović S
Cell Mol Life Sci; 2005 Jan; 62(1):77-86. PubMed ID: 15619009
[TBL] [Abstract][Full Text] [Related]
13. Role of an immunodominant T cell epitope of the P6 protein of nontypeable Haemophilus influenzae in murine protective immunity.
McMahon M; Murphy TF; Kyd J; Thanavala Y
Vaccine; 2005 May; 23(27):3590-6. PubMed ID: 15855018
[TBL] [Abstract][Full Text] [Related]
14. Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine.
De Groot AS; Bishop EA; Khan B; Lally M; Marcon L; Franco J; Mayer KH; Carpenter CC; Martin W
Methods; 2004 Dec; 34(4):476-87. PubMed ID: 15542374
[TBL] [Abstract][Full Text] [Related]
15. Mining the Leishmania genome for novel antigens and vaccine candidates.
Herrera-Najera C; Piña-Aguilar R; Xacur-Garcia F; Ramirez-Sierra MJ; Dumonteil E
Proteomics; 2009 Mar; 9(5):1293-301. PubMed ID: 19206109
[TBL] [Abstract][Full Text] [Related]
16. Vaccination strategy determines the emergence and dominance of CD8+ T-cell epitopes in a FVB/N rat HER-2/neu mouse model of breast cancer.
Singh R; Paterson Y
Cancer Res; 2006 Aug; 66(15):7748-57. PubMed ID: 16885378
[TBL] [Abstract][Full Text] [Related]
17. Computer-aided design of T-cell epitope-based vaccines: addressing population coverage.
Oyarzun P; Kobe B
Int J Immunogenet; 2015 Oct; 42(5):313-21. PubMed ID: 26211755
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and tolerance following HIV-1/HBV plant-based oral vaccine administration.
Guetard D; Greco R; Cervantes Gonzalez M; Celli S; Kostrzak A; Langlade-Demoyen P; Sala F; Wain-Hobson S; Sala M
Vaccine; 2008 Aug; 26(35):4477-85. PubMed ID: 18601967
[TBL] [Abstract][Full Text] [Related]
19. Statistical evaluation for detection of peptide specific interferon-gamma secreting T-cells induced by HIV vaccine determined by ELISPOT assay.
Periwal SB; Spagna K; Shahabi V; Quiroz J; Shroff KE
J Immunol Methods; 2005 Oct; 305(2):128-34. PubMed ID: 16181634
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients.
Mancini-Bourgine M; Bayard F; Soussan P; Deng Q; Lone YC; Kremsdorf D; Michel ML
J Virol; 2007 May; 81(10):4963-72. PubMed ID: 17360751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
